The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells

European Journal of Immunology

Volumn 33, Issue 4, 2003, Pages 970-979

  Workman, Creg J ^a   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Activation; CD223; LAG 3; Mouse; T cell

Indexed keywords

ANTIGEN; CD4 ANTIGEN DERIVATIVE; ENTEROTOXIN; GAMMA INTERFERON; GLUTAMIC ACID; INTERLEUKIN 2; ISOLEUCINE; LEUCINE; LYMPHOCYTE ACTIVATION PROTEIN; LYSINE; RETROVIRUS VECTOR; STAPHYLOCOCCUS TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; GENE EXPRESSION; GENE TRANSFER; GENETIC CONSERVATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; REGULATORY MECHANISM; REVIEW; STEM CELL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; CELL DEATH; ENTEROTOXINS; GENES, T-CELL RECEPTOR; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ALIGNMENT; T-LYMPHOCYTES;

EID: 0038068048     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323382     Document Type: Review

References (48)

1. + T cells. Nat. Immunol. 2000. 1: 107-111.
2. Waldmann, T. A., Dubois, S. and Tagaya, Y., Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001. 14: 105-110.
3. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
4. Chambers, C. A. and Allison, J. P., Co-stimulation in T cell responses. Curr. Opin. Immunol. 1997. 9: 396-404.
5. + T cells. Immunol. Rev. 1998. 165: 231-247.
6. Watts, T. H. and DeBenedette, M. A., T cell co-stimulatory molecules other than CD28. Curr. Opin. Immunol. 1999. 11: 286-293.
7. Oosterwegel, M. A., Greenwald, R. J., Mandelbrot, D. A., Lorsbach, R. B. and Sharpe, A. H., CTLA-4 and T cell activation. Curr. Opin. Immunol. 1999. 11: 294-300.
8. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995. 270: 985-988.
9. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
10. + T cells. Immunity 1997. 7: 885-895.
11. + T cell clone responses following LAG-3 binding. Eur. J. Immunol. 1996. 26: 1180-1186.
12. Baixeras, E., Huard, B., Miossec, C., Jitsukawa, S., Martin, M., Hercend, T., Auffray, C., Triebel, F. and Piatier-Tonneau, D., Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J. Exp. Med. 1992. 176: 327-337.
13. Hannier, S., Tournier, M., Bismuth, G. and Triebel, F., CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J. Immunol. 1998. 161: 4058-4065.
14. Bruniquel, D., Borie, N. and Triebel, F., Genomic organization of the human LAG-3/CD4 locus. Immunogenetics 1997. 47: 96-98.
15. Mastrangeli, R., Micangeli, E. and Donini, S., Cloning of murine LAG-3 by magnetic bead-bound homologous probes and PCR (gene-capture PCR). Anal. Biochem. 1996. 241: 93-102.
16. Triebel, F., Jitsukawa, S., Baixeras, E., Roman-Roman, S., Genevee, C., Viegas-Pequignot, E. and Hercend, T., LAG-3, a novel lymphocyte activation gene closely related to CD4. J. Exp. Med. 1990. 171: 1393-1405.
17. Huard, B., Gaulard, P., Faure, F., Hercend, T. and Triebel, F., Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Immunogenetics 1994. 39: 213-217.
18. Workman, C. J., Rice, D. S., Dugger, K. J., Kurschner, C. and Vignali, D. A. A., Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). Eur. J. Immunol. 2002. 32: 2255-2263.
19. Huard, B., Prigent, P., Tournier, M., Bruniquel, D. and Triebel, F., CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur. J. Immunol. 1995. 25: 2718-2721.
20. El Mir, S. and Triebel, F., A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens. J. Immunol. 2000. 164: 5583-5589.
21. Miyazaki, T., Dierich, A., Benoist, C. and Mathis, D., Independent modes of natural killing distinguished in mice lacking LAG 3. Science 1996. 272: 405-408.
22. Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A. and Thompson, C. B., Absence of B7-dependent responses in CD28-deficient mice. Immunity 1994. 1: 501-508.
23. Kawai, K., Shahinian, A., Mak, T. W. and Ohashi, P. S., Skin allograft rejection in CD28-deficient mice. Transplantation 1996. 61: 352-355.
24. Liao, X. C. and Littman, D. R., Altered T cell receptor signaling and disrupted T cell development in mice lacking ltk. Immunity 1995. 3: 757-769.
25. Waterhouse, P., Bachmann, M. F., Penninger, J. M., Ohashi, P. S. and Mak, T. W., Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 1997. 27: 1887-1892.
26. Bachmann, M. F., Waterhouse, P., Speiser, D. E., McKall-Faienza, K., Mak, T. W. and Ohashi, P. S., Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 1998. 160: 95-100.
27. White, J., Herman, A., Pullen, A. M., Kubo, R., Kappler, J. W. and Marrack, P., The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989. 56: 27-35.
28. Woodland, D. L. and Blackman, M. A., How do T cell receptors, MHC molecules and superantigens get together? Immunol. Today 1993. 14: 208-212.
29. Daly, K., Nguyen, P., Hankley, D., Zhang, W. J., Woodland, D. L. and Blackman, M. A., Contribution of the TCRα-chain to the differential recognition of bacterial and retroviral superantigens. J. Immunol. 1995. 155: 27-34.
30. Woodland, D. L., Wen, R. and Blackman, M. A., Why do super-antigens care about peptides? Immunol. Today 1997. 18: 18-22.
31. Barnden, M. J., Allison, J., Heath, W. R. and Carbone, F. R., Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell. Biol. 1998. 76: 34-40.
32. Workman, C. J., Dugger, K. J. and Vignali, D. A. A., Cutting Edge: The CD4-related molecule, LAG-3, regulates the expansion of activated T cells. J. Immunol. 2002. 169: 5392-5395.
33. Persons, D. A., Allay, J. A., Allay, E. R., Smeyne, R. J., Ashmun, R. A., Sorrentino, B. P. and Nienhuis, A. W., Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 1997. 90: 1777-1786.
34. + T lymphocytes. Eur. J. Immunol. 1994. 24: 3216-3221.
35. Vella, A. T., Dow, S., Potter, T. A., Kappler, J. and Marrack, P., Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 1998. 95: 3810-3815.
36. Takemoto, Y., Furuta, M., Li, X. K., Strong-Sparks, W. J. and Hashimoto, Y., LckBP1, a proline-rich protein expressed in haematopoietic lineage cells, directly associates with the SH3 domain of protein tyrosine kinase p56lck. EMBO J. 1995. 14: 3403-3414.
37. Fukamachi, H., Yamada, N., Miura, T., Kato, T., Ishikawa, M., Gulbins, E., Altman, A., Kawakami, Y. and Kawakami, T., Identification of a protein, SPY75, with repetitive helix-turn-helix motifs and an SH3 domain as a major substrate for protein tyrosine kinase(s) activated by Fc epsilon RI cross-linking. J. Immunol. 1994. 152: 642-652.
38. Iouzalen, N., Andreae, S., Hannier, S. and Triebel, F., LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway. Eur. J. Immunol. 2001. 31: 2885-2891.
39. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A., CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 1996. 183: 2541-2550.
40. Krummel, M. F. and Allison, J. P., CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996. 183: 2533-2540.
41. + T lymphocytes induced by CTLA-4 cross-linking. Proc. Natl. Acad. Sci. USA 1998. 95: 10083-10088.
42. Vignali, D. A. A. and Vignali, K. M., Profound enhancement of T cell activation mediated by the interaction between the T cell receptor and the D3 domain of CD4. J. Immunol. 1999. 162: 1431-1439.
43. Persons, D. A., Mehaffey, M. G., Kaleko, M., Nienhuis, A. W. and Vanin, E. F., An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 1998. 24: 167-182.
44. Markowitz, D., Goff, S. and Bank, A., A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 1988. 62: 1120-1124.
45. Carson, R. T., Vignali, K. M., Woodland, D. L. and Vignali, D. A. A., T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 1997. 7: 387-399.
46. Carson, R. T. and Vignali, D. A. A., Simultaneous quantitation of fifteen cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods 1999. 227: 41-52.
47. + T cells in the liver during the control and resolution phases of influenza pneumonia. Proc. Natl. Acad. Sci. USA 1998. 95: 13812-13817.
48. Allay, J. A., Dumenco, L. L., Koc, O. N., Liu, L. and Gerson, S. L., Retroviral transduction and expression of the human alkyl-transferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 1995. 85: 3342-3351.